Vanguard Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.23M | Buy |
518,269
+7,975
| +2% | +$34.4K | ﹤0.01% | 3502 |
|
|
2025
Q1 | $1.91M | Sell |
510,294
-5
| -0% | -$19 | ﹤0.01% | 3506 |
|
|
2024
Q4 | $5.17M | Hold |
510,299
| – | – | ﹤0.01% | 3258 |
|
|
2024
Q3 | $6.35M | Hold |
510,299
| – | – | ﹤0.01% | 3167 |
|
|
2024
Q2 | $6.64M | Sell |
510,299
-45,594
| -8% | -$593K | ﹤0.01% | 3121 |
|
|
2024
Q1 | $12.6M | Sell |
555,893
-24,784
| -4% | -$561K | ﹤0.01% | 2836 |
|
|
2023
Q4 | $7.53M | Sell |
580,677
-7,318
| -1% | -$95K | ﹤0.01% | 3106 |
|
|
2023
Q3 | $11.8M | Buy |
587,995
+9,053
| +2% | +$182K | ﹤0.01% | 2786 |
|
|
2023
Q2 | $15.5M | Buy |
578,942
+78,686
| +16% | +$2.11M | ﹤0.01% | 2702 |
|
|
2023
Q1 | $29.2M | Buy |
500,256
+153,756
| +44% | +$8.97M | ﹤0.01% | 2427 |
|
|
2022
Q4 | $17.7M | Buy |
346,500
+25,607
| +8% | +$1.31M | ﹤0.01% | 2677 |
|
|
2022
Q3 | $26.3M | Buy |
320,893
+39,428
| +14% | +$3.23M | ﹤0.01% | 2513 |
|
|
2022
Q2 | $19M | Buy |
281,465
+17,418
| +7% | +$1.18M | ﹤0.01% | 2660 |
|
|
2022
Q1 | $29.2M | Buy |
264,047
+40,127
| +18% | +$4.44M | ﹤0.01% | 2574 |
|
|
2021
Q4 | $21.6M | Sell |
223,920
-18,927
| -8% | -$1.83M | ﹤0.01% | 2801 |
|
|
2021
Q3 | $21.2M | Buy |
242,847
+1,958
| +0.8% | +$171K | ﹤0.01% | 2831 |
|
|
2021
Q2 | $37.3M | Buy |
240,889
+3,792
| +2% | +$587K | ﹤0.01% | 2523 |
|
|
2021
Q1 | $37.4M | Buy |
237,097
+5,070
| +2% | +$800K | ﹤0.01% | 2463 |
|
|
2020
Q4 | $53.9M | Buy |
232,027
+2,423
| +1% | +$563K | ﹤0.01% | 2159 |
|
|
2020
Q3 | $50.3M | Sell |
229,604
-7,996
| -3% | -$1.75M | ﹤0.01% | 2016 |
|
|
2020
Q2 | $67.5M | Buy |
237,600
+21,036
| +10% | +$5.98M | ﹤0.01% | 1853 |
|
|
2020
Q1 | $62.4M | Buy |
216,564
+32,171
| +17% | +$9.27M | ﹤0.01% | 1760 |
|
|
2019
Q4 | $53M | Buy |
184,393
+1,422
| +0.8% | +$409K | ﹤0.01% | 2086 |
|
|
2019
Q3 | $26.4M | Sell |
182,971
-15,953
| -8% | -$2.3M | ﹤0.01% | 2342 |
|
|
2019
Q2 | $17.9M | Buy |
198,924
+24,639
| +14% | +$2.21M | ﹤0.01% | 2567 |
|
|
2019
Q1 | $15.3M | Buy |
174,285
+59,026
| +51% | +$5.17M | ﹤0.01% | 2626 |
|
|
2018
Q4 | $16.2M | Sell |
115,259
-45,600
| -28% | -$6.41M | ﹤0.01% | 2530 |
|
|
2018
Q3 | $41.1M | Sell |
160,859
-5,355
| -3% | -$1.37M | ﹤0.01% | 2242 |
|
|
2018
Q2 | $42.4M | Buy |
166,214
+37,144
| +29% | +$9.47M | ﹤0.01% | 2208 |
|
|
2018
Q1 | $26M | Buy |
129,070
+8,977
| +7% | +$1.81M | ﹤0.01% | 2386 |
|
|
2017
Q4 | $17.3M | Buy |
120,093
+2,115
| +2% | +$305K | ﹤0.01% | 2546 |
|
|
2017
Q3 | $19.4M | Buy |
117,978
+9,883
| +9% | +$1.63M | ﹤0.01% | 2500 |
|
|
2017
Q2 | $14.7M | Buy |
108,095
+25,644
| +31% | +$3.48M | ﹤0.01% | 2593 |
|
|
2017
Q1 | $15.9M | Buy |
82,451
+7,340
| +10% | +$1.41M | ﹤0.01% | 2545 |
|
|
2016
Q4 | $10.6M | Buy |
75,111
+16,337
| +28% | +$2.3M | ﹤0.01% | 2719 |
|
|
2016
Q3 | $8.58M | Buy |
58,774
+4,344
| +8% | +$634K | ﹤0.01% | 2762 |
|
|
2016
Q2 | $5.48M | Buy |
54,430
+8,515
| +19% | +$857K | ﹤0.01% | 2930 |
|
|
2016
Q1 | $6.14M | Sell |
45,915
-889
| -2% | -$119K | ﹤0.01% | 2853 |
|
|
2015
Q4 | $9.3M | Buy |
46,804
+253
| +0.5% | +$50.3K | ﹤0.01% | 2677 |
|
|
2015
Q3 | $7.35M | Sell |
46,551
-163
| -0.3% | -$25.7K | ﹤0.01% | 2780 |
|
|
2015
Q2 | $19.1M | Buy |
46,714
+9,244
| +25% | +$3.77M | ﹤0.01% | 2377 |
|
|
2015
Q1 | $17.2M | Buy |
37,470
+9,757
| +35% | +$4.48M | ﹤0.01% | 2387 |
|
|
2014
Q4 | $15.6M | Buy |
27,713
+2,300
| +9% | +$1.29M | ﹤0.01% | 2356 |
|
|
2014
Q3 | $13.3M | Buy |
25,413
+5,653
| +29% | +$2.96M | ﹤0.01% | 2374 |
|
|
2014
Q2 | $13.8M | Buy |
19,760
+10,187
| +106% | +$7.11M | ﹤0.01% | 2370 |
|
|
2014
Q1 | $4.44M | Buy |
9,573
+4,351
| +83% | +$2.02M | ﹤0.01% | 2889 |
|
|
2013
Q4 | $1.8M | Buy |
+5,222
| New | +$1.8M | ﹤0.01% | 3227 |
|